BioSpace News Archive

The Center for Reproductive Health and Gynecology (CRHG) is excited to announce the next step in increasing fertility rates. Fertility Focused Naturopathic Medicine Consultations and IV Therapy will now be offered at their Beverly Hills location by Naturopathic Doctor, Dr. Raquel Hammonds, along with multiple packages and personalized plans.

The market will accelerate at a CAGR of over 4% between 2019-2023

Globe Life Inc. will release Third Quarter 2019 earnings after the market closes on Wednesday, Oct. 23 2019.

The market will accelerate at a CAGR of over 5% between 2019-2023

Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a conditional marketing authorization for V920 Ebola Zaire vaccine If affirmed by the European Commission, the vaccine will be authorized under the brand name ERVEBO® and indicated for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease caused by Zaire Ebola virus.

Castle Biosciences, Inc. announced the presentation of data supporting the ability of the DecisionDx®-Melanoma gene expression profile test to identify T1 melanoma patients at low risk for a positive sentinel lymph node at the American Society of Dermatopathology 56th Annual Meeting in San Diego from October 17-20.

Over two-thirds (68 per cent) of Canadians believe the federal government does not provide enough healthcare funding to the provinces, according to a new Ipsos poll.

Mark Lashley, President and CEO of Caregiver, Inc., a leading provider of services to adults with intellectual and developmental disabilities (IDD), has named Beth Landry Caregiver’s first Chief Operating Officer (COO).

As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC in Canada and the U.S. This recall is being taken due to possible contamination with a nitrosamine impurity called N-nitrosodimethylamine and will be initiated, in Canada, at the pharmacy and retail store level..

As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC in the U.S. and Canada.